Kiora Pharmaceuticals Inc. (KPRX:NASDAQ) rocketted at $6.94, a gain of 52.5%. On Wed, Feb 08, 2023, KPRX:NASDAQ hit a New 2-Week High of $6.94. The stock got featured on our News Catalysts scanner on Tue, Feb 07, 2023 at 09:54 AM in the 'BIOTECH' category. From Wed, Jan 25, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Aug 25, 2022 at $12.28 with a volume of 7M+.
About Kiora Pharmaceuticals Inc. (KPRX:NASDAQ)
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 187.13%
- AVROBIO, Inc. (AVRO:NASDAQ), 93.7%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 58.36%
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 52.53%
- PainReform Ltd. (PRFX:NASDAQ), 44.72%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 33.98%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 29.14%
- VIQ Solutions Inc. (VQS:NASDAQ), 28.9%
- SoundHound AI Inc. (SOUN:NASDAQ), 28.61%
- TH International Limited (THCH:NASDAQ), 26.19%